Stock Screener

Stock Screener · Library

GT Biopharma, Inc. financial statement history

Source-linked financial facts for GT Biopharma, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.

What this record covers

This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.

Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.

Total assets

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3132169000USD2023-03-302022 / FYus-gaap:Assets10-K · 0001493152-23-009812
As of 2022-12-3116736000USD2024-03-262023 / FYus-gaap:Assets10-K · 0001493152-24-011332
As of 2023-12-3114109000USD2025-02-212024 / FYus-gaap:Assets10-K · 0001493152-25-007908
As of 2024-12-314232000USD2026-03-022025 / FYus-gaap:Assets10-K · 0001493152-26-008443
As of 2025-06-307124000USD2026-03-022025 / FYus-gaap:Assets10-K · 0001493152-26-008443
As of 2025-09-304321000USD2026-03-022025 / FYus-gaap:Assets10-K · 0001493152-26-008443
As of 2025-12-318106000USD2026-03-022025 / FYus-gaap:Assets10-K · 0001493152-26-008443

Current assets

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3132169000USD2023-03-302022 / FYus-gaap:AssetsCurrent10-K · 0001493152-23-009812
As of 2022-12-3116562000USD2024-03-262023 / FYus-gaap:AssetsCurrent10-K · 0001493152-24-011332
As of 2023-12-3114056000USD2025-02-212024 / FYus-gaap:AssetsCurrent10-K · 0001493152-25-007908
As of 2024-12-314232000USD2026-03-022025 / FYus-gaap:AssetsCurrent10-K · 0001493152-26-008443
As of 2025-12-318106000USD2026-03-022025 / FYus-gaap:AssetsCurrent10-K · 0001493152-26-008443

Cash and cash equivalents

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-318968000USD2023-03-302022 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001493152-23-009812
As of 2022-12-315672000USD2024-03-262023 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001493152-24-011332
As of 2023-12-311079000USD2025-02-212024 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001493152-25-007908
As of 2024-12-313951000USD2026-03-022025 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001493152-26-008443
As of 2025-12-316811000USD2026-03-022025 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001493152-26-008443

Total liabilities

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3110259000USD2023-03-302022 / FYus-gaap:Liabilities10-K · 0001493152-23-009812
As of 2022-12-315002000USD2024-03-262023 / FYus-gaap:Liabilities10-K · 0001493152-24-011332
As of 2023-12-316633000USD2024-03-262023 / FYus-gaap:Liabilities10-K · 0001493152-24-011332
As of 2025-06-3031043000USD2026-03-022025 / FYus-gaap:Liabilities10-K · 0001493152-26-008443
As of 2025-09-301321000USD2026-03-022025 / FYus-gaap:Liabilities10-K · 0001493152-26-008443

Current liabilities

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3110259000USD2023-03-302022 / FYus-gaap:LiabilitiesCurrent10-K · 0001493152-23-009812
As of 2022-12-314938000USD2024-03-262023 / FYus-gaap:LiabilitiesCurrent10-K · 0001493152-24-011332
As of 2023-12-316633000USD2025-02-212024 / FYus-gaap:LiabilitiesCurrent10-K · 0001493152-25-007908
As of 2024-12-315902000USD2026-03-022025 / FYus-gaap:LiabilitiesCurrent10-K · 0001493152-26-008443
As of 2025-12-312319000USD2026-03-022025 / FYus-gaap:LiabilitiesCurrent10-K · 0001493152-26-008443

Stockholders equity

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3121910000USD2024-03-262023 / FYus-gaap:StockholdersEquity10-K · 0001493152-24-011332
As of 2022-12-3111734000USD2025-02-212024 / FYus-gaap:StockholdersEquity10-K · 0001493152-25-007908
As of 2023-12-317476000USD2026-03-022025 / FYus-gaap:StockholdersEquity10-K · 0001493152-26-008443
As of 2024-12-31-1670000USD2026-03-022025 / FYus-gaap:StockholdersEquity10-K · 0001493152-26-008443
As of 2025-06-30-25875000USD2026-03-022025 / FYus-gaap:StockholdersEquity10-K · 0001493152-26-008443
As of 2025-09-303000000USD2026-03-022025 / FYus-gaap:StockholdersEquity10-K · 0001493152-26-008443
As of 2025-12-315787000USD2026-03-022025 / FYus-gaap:StockholdersEquity10-K · 0001493152-26-008443

Research and development

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-319591000USD2023-03-302022 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001493152-23-009812
2022-01-01 to 2022-12-318811000USD2024-03-262023 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001493152-24-011332
2023-01-01 to 2023-12-316466000USD2025-02-212024 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001493152-25-007908
2024-01-01 to 2024-12-315798000USD2026-03-022025 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001493152-26-008443
2025-01-01 to 2025-12-313472000USD2026-03-022025 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001493152-26-008443

Operating income

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-57515000USD2023-03-302022 / FYus-gaap:OperatingIncomeLoss10-K · 0001493152-23-009812
2022-01-01 to 2022-12-31-21257000USD2024-03-262023 / FYus-gaap:OperatingIncomeLoss10-K · 0001493152-24-011332
2023-01-01 to 2023-12-31-13576000USD2025-02-212024 / FYus-gaap:OperatingIncomeLoss10-K · 0001493152-25-007908
2024-01-01 to 2024-12-31-14364000USD2026-03-022025 / FYus-gaap:OperatingIncomeLoss10-K · 0001493152-26-008443
2025-01-01 to 2025-12-31-12422000USD2026-03-022025 / FYus-gaap:OperatingIncomeLoss10-K · 0001493152-26-008443

Net income

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-58013000USD2023-03-302022 / FYus-gaap:NetIncomeLoss10-K · 0001493152-23-009812
2022-01-01 to 2022-12-31-20884000USD2024-03-262023 / FYus-gaap:NetIncomeLoss10-K · 0001493152-24-011332
2023-01-01 to 2023-12-31-7597000USD2025-02-212024 / FYus-gaap:NetIncomeLoss10-K · 0001493152-25-007908
2024-01-01 to 2024-12-31-13162000USD2026-03-022025 / FYus-gaap:NetIncomeLoss10-K · 0001493152-26-008443
2025-01-01 to 2025-12-31-28354000USD2026-03-022025 / FYus-gaap:NetIncomeLoss10-K · 0001493152-26-008443

Diluted earnings per share

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2022-01-01 to 2022-12-31-19.66USD/shares2024-03-262023 / FYus-gaap:EarningsPerShareDiluted10-K · 0001493152-24-011332
2023-01-01 to 2023-12-31-5.64USD/shares2025-02-212024 / FYus-gaap:EarningsPerShareDiluted10-K · 0001493152-25-007908
2024-01-01 to 2024-12-31-6.94USD/shares2026-03-022025 / FYus-gaap:EarningsPerShareDiluted10-K · 0001493152-26-008443
2025-01-01 to 2025-12-31-6.68USD/shares2026-03-022025 / FYus-gaap:EarningsPerShareDiluted10-K · 0001493152-26-008443

Operating cash flow

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2021-01-01 to 2021-12-31-15606000USD2023-03-302022 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001493152-23-009812
2022-01-01 to 2022-12-31-15217000USD2024-03-262023 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001493152-24-011332
2023-01-01 to 2023-12-31-8852000USD2025-02-212024 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001493152-25-007908
2024-01-01 to 2024-12-31-12904000USD2026-03-022025 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001493152-26-008443
2025-01-01 to 2025-12-31-12914000USD2026-03-022025 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001493152-26-008443

Dividends paid

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2025-01-01 to 2025-12-31229000USD2026-03-022025 / FYus-gaap:PaymentsOfDividends10-K · 0001493152-26-008443

Source and method

SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.

The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.

Source filer CIK
109657
Ticker in native snapshot
GTBP
Reported numeric facts
59
Units present
USD · USD/shares